Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
05/2009
05/13/2009CN101429134A New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof
05/12/2009US7531692 wherein the carboxylic group is linked to a residue allowing the passage of the blood-brain barrier; residue is represented by the amide of an alpha-amino acid and preferably is glycinamide; beta amyloid peptide (A beta 42) antagonist; Alzheimer's disease
05/12/2009US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo
05/12/2009US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis
05/12/2009US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
05/12/2009US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
05/09/2009CA2643622A1 New crystalline form vi of agometaline, the process for making it and pharmaceutical compositions containing it
05/07/2009WO2009057528A1 Kit for use in production of molecular probe for pet drug screening
05/07/2009WO2009056575A1 Process for the preparation of substituted 7-allyl-6-hydroxy-indanes
05/07/2009WO2009036175A3 F1f0-atpase inhibitors and related methods
05/07/2009WO2009029888A3 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
05/07/2009WO2009009041A3 Compositions and methods for modulating a kinase cascade
05/07/2009WO2008088540A4 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
05/07/2009WO2007044752A3 Treating skin disorders
05/07/2009US20090118544 Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine
05/07/2009US20090118357 Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
05/07/2009US20090118338 Aryl amides useful as inhibitors of voltage-gated sodium channels
05/07/2009US20090118242 Injectable capsaicin with non-steroidal anti-inflammatory adjunctive agent
05/07/2009US20090118169 Novel compounds and pharmaceutical use thereof
05/07/2009US20090117167 Injectable capsaicin with vasocontrictor adjunctive agent
05/07/2009CA2703186A1 Process for the preparation of substituted 7-allyl-6-hydroxy-indanes
05/06/2009EP2055689A1 Method for producing an optically active nitro compound
05/06/2009EP2054370A1 Integrated process and apparatus for preparing esters of methacrylic acid from acetone and hydrocyanic acid
05/06/2009CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases
05/06/2009CN100484914C 1-carbamoylcycloalkylcarboxylic acid compounds, processes fro making and uses thereof
05/06/2009CN100484400C Diphenylethylene compound
04/2009
04/30/2009WO2009054202A1 Process for producing organic compound and organic compound obtained by the same
04/30/2009WO2009053443A2 Indane compounds
04/30/2009WO2009053128A2 Method for amidating of nitrile in the presence of sulfuric acid
04/30/2009WO2009030964A3 Amphiphilic oxalamide organogelators designed for gelation of organic solvents, water and hydrocarbon commercial fuels
04/30/2009WO2009026422A3 Treatment of central nervous system disorders
04/30/2009WO2009004643A3 An improved process for preparation of (s)-pregabalin and intermediates thereof
04/30/2009WO2008117175A3 Novel benzamide derivatives as modulators of the follicle stimulating hormone
04/30/2009WO2005113485A3 Stable nateglinide form b compositions
04/30/2009US20090112004 Synthesis of quaternary salt compounds
04/30/2009US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis
04/30/2009US20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists
04/30/2009US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
04/30/2009US20090111792 Injectable capsaicin with tricyclic antidepressant adjunctive agent
04/30/2009US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex
04/30/2009US20090108230 such as octadecyl octadecamide and octadecyl dodecamide; mechanical properties; for thermo-mechanical device; high melting point, nontoxic, low vapor pressure, heat resistance, moisture resistance, odorless, rapid crystallization rate, low cost
04/30/2009CA2695234A1 Novel method for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine
04/29/2009EP2051964A2 Fatty acid amide hydrolase inhibitors
04/29/2009EP2051958A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
04/29/2009EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof
04/29/2009EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists
04/29/2009CN101421229A Improved crystalline material
04/29/2009CN101421228A Preparation of chiral amides and amines
04/29/2009CN101421218A Cycloalkyl-phenylsubstituierte cyclische ketoenole
04/29/2009CN101417960A Method for preparing 1,1-cyclohexanediacetic acid mono amide
04/29/2009CN100482649C Organic compounds
04/29/2009CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
04/29/2009CN100482637C Compounds and compositions for delivering active agents
04/29/2009CN100482635C Noval compounds, their use and preparation
04/28/2009USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma
04/28/2009US7524984 To reduce viscosity of a thermoplastic at high temperatures
04/28/2009US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/28/2009US7524883 Eponemycin and epoxomicin analogs and uses thereof
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009CA2446944C Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
04/28/2009CA2361716C Method of preparing alkylated salicylamides
04/28/2009CA2339765C Compounds and compositions for delivering active agents
04/23/2009WO2009052341A1 Gsm intermediates
04/23/2009WO2009052079A1 Amide linked modulators of y-secretase
04/23/2009WO2009051910A1 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
04/23/2009WO2009050483A1 Cationic lipids
04/23/2009WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1
04/23/2009WO2007096807A3 Process for the preparation of zaleplon and an intermediate thereof
04/23/2009WO2007056134A3 Resorbable phenolic polymers
04/23/2009WO2006047740A3 Heat shock protein 90 inhibitors
04/23/2009US20090105437 High refractive index pressure-sensitive adhesives
04/23/2009US20090105347 Thyronamine derivatives and analogs and methods of use thereof
04/23/2009US20090105346 Novel crystalline forms of armodafinil and preparation thereof
04/23/2009US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation
04/23/2009US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/23/2009US20090105258 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
04/23/2009US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
04/23/2009US20090105220 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
04/23/2009CA2702911A1 Gsm intermediates
04/23/2009CA2702862A1 Cationic lipids
04/23/2009CA2702835A1 Amide linked modulators of .gamma.-secretase
04/22/2009EP2050766A2 Polymeric Photoinitiators
04/22/2009EP2050734A1 Pentadienamide derivative
04/22/2009EP2049469A2 Process for preparing amidrazones
04/22/2009EP2049463A1 A process for the preparation of optically active cyclopropylamines
04/22/2009EP1915337A4 Hydroxybenzamide derivatives, the method for preparing thereof and the cosmetic composition containing the same
04/22/2009EP1585757A4 Peptide deformylase inhibitors
04/22/2009EP1285908B9 Substituted phenylpropionic acid derivatives
04/22/2009CN101415832A Process for production of acrylamide
04/22/2009CN101415668A Methods for producing carboxylic acid chloride compounds
04/22/2009CN100480701C Perfluoro sulfonyl halides and related species as polymer support modifiers
04/22/2009CN100480233C Method for producing phenylalanine derivative and synthetic intermediate thereof
04/21/2009US7521579 Process for the preparation of alpha hydroxycarboxylic acid amides
04/21/2009US7521544 Photo-initiated carbonylation with carbon-isotope labeled carbon monoxide using amines and alkyl/aryl iodides; carbon-isotope labeled amides are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography
04/21/2009US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia
04/16/2009WO2009049183A1 Aryl amides useful as inhibitors of voltage-gated sodium channels
04/16/2009WO2009023718A3 Novel activators of glucokinase
04/16/2009WO2009022066A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/16/2009WO2009022065A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/16/2009WO2009022064A3 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 289